Form 4: NeueHealth Executive Jeffrey Scherman Reports Stock Transactions

Jeffrey Scherman, Chief Accounting Officer of NeueHealth, Inc., reports the vesting and disposal of restricted stock units.

Summary

• On March 6, 2025, Jeffrey J. Scherman, Chief Accounting Officer of NeueHealth, Inc., reported transactions involving the company's stock.
• Scherman disposed of 2,491 shares of common stock.
• These shares were acquired through the vesting of restricted stock units.
• Following the reported transactions, Scherman directly owns 2,490 derivative securities and 8,433 shares of common stock.

Sentiment

Score: 5

Explanation: This is a routine regulatory filing related to stock transactions by an insider. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership by a company insider.
• The transactions have no direct impact on employees, customers, suppliers, or creditors.

Key Dates